Skip to content

Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis

Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01556503
Enrollment
24
Registered
2012-03-16
Start date
2011-04-30
Completion date
2013-11-30
Last updated
2016-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma

Brief summary

The purpose of this study is to show how well a new device, confocal microscope, works to detect malignant melanoma, a type of skin cancer.

Interventions

DEVICEVivaScope System

VivaScope System, Model#s 1500 and 2500

Sponsors

OHSU Knight Cancer Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 12 or older * Patient who has already been selected by their dermatologist for biopsy of a suspicious pigmented lesion and who consents to participate in the study * Signed informed consent

Exclusion criteria

* Age \< 12 years

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity of confocal microscope to improve melanoma detectionUp to 1 yearDetermine the sensitivity of confocal microscopy in the diagnosis of melanoma by comparison to the gold standard histopathologic diagnosis.
Specificity of the confocal microscope to improve melanoma detectionUp to 1 yearDetermine the specificity of confocal microscopy in the diagnosis of melanoma by comparison to the gold standard histopathologic diagnosis

Secondary

MeasureTime frameDescription
Patterns seen on the confocal imageUp to 1 yearEvaluate and confirm patterns seen on the confocal image, which are characteristic of melanoma and atypical nevi: A) Pagetoid melanoma cells: melanocytes in suprabasal areas of the epidermis B) Irregular dermal-epidermal junction

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026